Skip to content

Effect of n-3 PUFA From Fish in Enteral Nutrition of Major Burn Patients

Effect of Omega-3 PUFA From Fish in Major Burn Patients. EFECTO DE ÁCIDOS GRASOS POLIINSATURADOS OMEGA 3 DERIVADOS DE ACEITE DE PESCADO, EN QUEMADOS GRAVES

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02189538
Acronym
OmegaBurn
Enrollment
100
Registered
2014-07-14
Start date
2013-01-31
Completion date
2018-02-28
Last updated
2017-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn Injury

Keywords

Infections, Enteral nutrition, SIRS, critically ill

Brief summary

Studies have shown that burn patients may benefit from low fat diets, but there is still no strong data regarding the impact of fatty acid composition used for feeding. The trial test the hypothesis that the inclusion of omega-3 PUFA in a low fat diet may improve outcome. Prospective randomised controlled trial in adult patients admitted for burns \> 15% body surface area (BSA), and inhalation injury requiring mechanical ventilation and enteral nutrition. On admission randomization to receive a low-fat (18% energy as fat) modular enteral diet (LF-EN) and identical with the half of fat provided by fish oil (FO-EN). Study endpoints: mechanical ventilation time, inflammation (CRP), infectious and other complications, mortality until discharge. The study is planed as 2 parts: 1) preliminary study testing the feasibility of the study, 2) the study completed with information from the preliminary phase, both phases being randomised and controlled.

Detailed description

Randomisation within the first 24 hours of admission to 2 types of enteral feeds: 1) ω 3 PUFA (FO-EN) or 2) control solution which is the hospitals standard low 18% fat containing solution. The patients are fed as long as clinically required with the initial solution.

Interventions

DIETARY_SUPPLEMENTω-3 PUFA

The patients are fed as long as the clinically required with the randomly attributed enteral solution.

DIETARY_SUPPLEMENTLow fat enteral diet

The patients are fed as long as the clinically required with the randomly attributed enteral solution

Sponsors

Centro Nacional de Quemados, Uruguay
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
16 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

\- adult \>16 years, burns \> 15% BSA, mechanical ventilation, next of kin consent

Exclusion criteria

* absence of the above, absence of commitment to full treatment * comorbidities (cancer, COPD, diabetes, liver failure (Child Pugh B and C) * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Number of infectionsup to Day 28 after burn injuryInfectious complications will be recorded according to CDC criteria, and grouped as pulmonary, blood stream infections (catheter related or not), cutaneous, abdominal and others

Secondary

MeasureTime frameDescription
Non infectious complicationsup to day 28Any complication will be recorded during the above time frame

Other

MeasureTime frameDescription
Duration of mechanical ventilationup to day 28Time on mechanical ventilation though an endotracheal tube (naso-tracheal or tracheostomy)
Length of ICU and hospital stayup to day 28ICU and hospital to discharge but maximum for 28 days
MortalityHospital stay
Magnitude of CRP increaseduring ICU stay and up to day 28C-reactive protein as determined for clinical purpose, Temperature (maximal T° per day), Leucocytes

Countries

Uruguay

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026